ABUS vs FOX
Arbutus Biopharma Corp (ABUS) versus Fox Corp Class B (FOX) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Not investment advice. Open the ABUS and FOX stock pages for the full models.
Not investment advice.